论文部分内容阅读
本刊讯8月4日,北京市食品药品监督管理局药品注册处召集北京生物医药创新促进平台相关成员单位召开儿童药品研发专题会,通过会议了解企业需求和建议。会上,市食药监管局药品注册处代表介绍了北京市儿童药品注册情况,分析了北京市现有儿童药品批准文号及儿童专用医疗机构制剂批准文号的组成及分布特点,通报了北京市主持、参与的儿童用药相关国家重大创新研制专项课题及北京市科技计划课题情况。来自中国医学科学院药物研究所、首都医科大
On August 4, the Drug Registry of Beijing Food and Drug Administration convened the relevant member units of Beijing Biomedical Innovation Promotion Platform to hold a special session on children’s drug research and development, and learned about the needs and suggestions of enterprises through the meeting. At the meeting, representatives of the Drug Regulatory Office of the City Food and Drug Administration introduced the registration of children’s medicines in Beijing, analyzed the composition and distribution characteristics of the existing children’s drug approval number and the approval number of the children-only medical institution in Beijing, and informed Beijing City presided over the participation of children drug-related major national innovation and development projects and Beijing Science and Technology Plan topics. From Institute of Materia Medica, Chinese Academy of Medical Sciences, Capital Medical University